Volpara software is used to assess the breast density of more than 1 million Australian women annually. WELLINGTON, New Zealand, June 2, 2025 /PRNewswire/ -- Volpara Health, a Lun ...

Carter, who stars on The Real Housewives of Atlanta, has revealed she has been diagnosed with breast cancer, with the reality ...

Diliman have developed an analytical model that could detect early signs of metastasis, or spread of tumor, in breast cancer ...

AstraZeneca's experimental drug, camizestrant, significantly reduces the risk of breast cancer progression or death in ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

It is the first worldwide study to show that using blood tests to find early signs of cancer resistance to treatment helps ...

Oklahoma lawmakers overrode Governor Stitt's veto on a bill enhancing access to advanced breast cancer screenings, ensuring ...

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

Camizestrant plus CDK4/6 inhibition improved progression-free survival when given to patients with ESR1-mutant ER+/HER2– ...

Approximately 70% of breast cancers are HR-positive/HER2 negative. While activating ESR1 mutations are rare at the time of ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Erin Cobain, MD, discusses findings from a study exploring the differences in diagnosis and treatment of high-risk breast cancer in Black and White patients.